{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Aly KA"],"funding":["National Institutes of Health","NIGMS NIH HHS","Canadian Institutes of Health Research"],"pagination":["102030"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7820543"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["24(2)"],"pubmed_abstract":["Mitochondrial (mt) dysfunction is linked to rare diseases (RDs) such as respiratory chain complex (RCC) deficiency, MELAS, and ARSACS. Yet, how altered mt protein networks contribute to these ailments remains understudied. In this perspective article, we identified 21 mt proteins from public repositories that associate with RCC deficiency, MELAS, or ARSACS, engaging in a relatively small number of protein-protein interactions (PPIs), underscoring the need for advanced proteomic and interactomic platforms to uncover the complete scope of mt connectivity to RDs. Accordingly, we discuss innovative untargeted label-free proteomics in identifying RD-specific mt or other macromolecular assemblies and mapping of protein networks in complex tissue, organoid, and stem cell-differentiated neurons. F"],"journal":["iScience"],"pubmed_title":["From fuzziness to precision medicine: on the rapidly evolving proteomics with implications in mitochondrial connectivity to rare human disease."],"pmcid":["PMC7820543"],"funding_grant_id":["R01 GM106019"],"pubmed_authors":["Moutaoufik MT","Phanse S","Babu M","Aly KA","Zhang Q"],"additional_accession":[]},"is_claimable":false,"name":"From fuzziness to precision medicine: on the rapidly evolving proteomics with implications in mitochondrial connectivity to rare human disease.","description":"Mitochondrial (mt) dysfunction is linked to rare diseases (RDs) such as respiratory chain complex (RCC) deficiency, MELAS, and ARSACS. Yet, how altered mt protein networks contribute to these ailments remains understudied. In this perspective article, we identified 21 mt proteins from public repositories that associate with RCC deficiency, MELAS, or ARSACS, engaging in a relatively small number of protein-protein interactions (PPIs), underscoring the need for advanced proteomic and interactomic platforms to uncover the complete scope of mt connectivity to RDs. Accordingly, we discuss innovative untargeted label-free proteomics in identifying RD-specific mt or other macromolecular assemblies and mapping of protein networks in complex tissue, organoid, and stem cell-differentiated neurons. F","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Feb","modification":"2026-07-10T03:20:18.199Z","creation":"2021-02-21T05:07:36Z"},"accession":"S-EPMC7820543","cross_references":{"pubmed":["33521598"],"doi":["10.1016/j.isci.2020.102030"]}}